- Potential benefitIncreased public awareness may prompt earlier diagnosis and treatment-seeking by symptomatic individuals.
- Potential benefitAdvocacy for research funding could help accelerate development of better treatments and diagnostics.
- Potential benefitLinking families to nonprofit support networks may improve patient and caregiver psychosocial outcomes.
Support Awareness and Research for Bone Marrow Diseases
Referred to the Subcommittee on Health.
This resolution expresses the sense of Congress about bone marrow diseases and urges greater awareness, research, and support services. It is a non-binding statement adopted by both chambers that recommends actions but does not create legal requirements or authorize spending. It calls on the federal government to raise awareness, fund research, engage in public health initiatives, and improve access to care.
Concurrent resolutions are adopted by both the House and Senate but are not presented to the President and do not have the force of law. They record the collective view or request of Congress and can encourage executive action without creating binding obligations.
This concurrent resolution expresses the sense of Congress about bone marrow diseases (aplastic anemia, MDS, PNH).
It urges public awareness, access to treatments and counseling, links to nonprofit support, and federal efforts for research, surveillance, education, and improved access to care.
The resolution is non-binding and requests but does not mandate funding or specific programs.
Concurrent resolution is nonbinding and does not become law; adoption is likely but it cannot become statute.
Relative to its intended legislative type, this concurrent resolution is a well-defined expression of concern and priority-setting statement with clear problem articulation but minimal operational detail. It functions primarily to raise awareness and encourage federal attention rather than to change law or create binding obligations.
Whether the resolution should trigger new federal funding
Who stands to gain, and who may push back.
These are examples from the analysis, not a ranked list of the most-affected groups.
- Potential burdenAs a nonbinding resolution, it creates no legal obligations or immediate funding changes.
- Federal agenciesPhrases like "adequate funding" could raise expectations for new federal spending without specifics.
- Potential burdenCalls for expanded surveillance may raise patient privacy and data-sharing concerns.
Why the argument around this bill splits.
Whether the resolution should trigger new federal funding
Likely strongly supportive.
Views the resolution as a helpful, bipartisan signal to increase research funding, patient support, and equitable access to care.
Wants concrete follow-up actions ensuring underserved populations benefit.
Generally favorable.
Sees this as a low-conflict, commonsense expression that raises awareness and could justify targeted, cost-effective federal actions.
Wants measurable goals and fiscal responsibility for any spending.
Generally supportive of the resolution's goals but cautious about expanding federal roles.
Prefers reliance on nonprofits, private research, and existing federal programs rather than new mandatory spending.
The path through Congress.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Concurrent resolution is nonbinding and does not become law; adoption is likely but it cannot become statute.
- Whether a companion or similar measure is introduced in the Senate
- Whether committee schedules this resolution for floor consideration
Recent votes on the bill.
No vote history yet
The bill has not accumulated any surfaced votes yet.
Go deeper than the headline read.
Whether the resolution should trigger new federal funding
Concurrent resolution is nonbinding and does not become law; adoption is likely but it cannot become statute.
Relative to its intended legislative type, this concurrent resolution is a well-defined expression of concern and priority-setting statement with clear problem articulation but minimal operational detail. It functions p…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.